$221.32
-1.19-0.53%
At close: May 8, 5:00 PM EST
$221.44
0.120.05%
After Hours: 7:53 PM EST
Johnson & Johnson Stock Guidance
JNJNYSE
Johnson & Johnson (JNJ) last issued guidance on April 14, 2026 for fiscal year 2026. The company guided earnings per share in the range of $11.45 - $11.65, compared to a consensus EPS estimate of $11.56. Johnson & Johnson also guided revenue in the range of $100.30B - $101.30B for the period.
Compared to prior guidance, Johnson & Johnson maintained its EPS outlook from a previous range of $11.43 - $11.63. On the revenue side, the company maintained its revenue forecast from a prior range of $100.00B - $101.00B.
Johnson & Johnson has issued 20 guidance updates between July 19, 2022 and April 14, 2026. During this period, the company raised its outlook 6 times and lowered it 4 times, providing investors with insight into management's evolving expectations.
Latest Guidance Date
Apr 14, 2026
Guidance Period
Full Year 2026
EPS Guidance Range
$11.45 - $11.65
Revenue Guidance Range
$100.30B - $101.30B
Johnson & Johnson Guidance History
Review all historical guidance issued by Johnson & Johnson, including EPS and revenue forecasts across quarterly and annual periods.
Loading calendar...
FAQ
What is the most recent guidance for Johnson & Johnson (JNJ)?
The most recent guidance for Johnson & Johnson (JNJ) was reported on April 14, 2026 for the fiscal year 2026. The company provided earnings per share guidance in the range of $11.45 to $11.65, compared to the estimated EPS of $11.56. Additionally, Johnson & Johnson forecasted revenue between $100.30B and $101.30B for the period.
What EPS range did Johnson & Johnson (JNJ) guide for?
Johnson & Johnson (JNJ) guided EPS in the range of $11.45 to $11.65 for the fiscal year 2026. The consensus analyst EPS estimate is $11.56.
What revenue range did Johnson & Johnson (JNJ) guide for?
Johnson & Johnson (JNJ) guided revenue in the range of $100.30B to $101.30B for the fiscal year 2026.
Did Johnson & Johnson (JNJ) raise or lower guidance?
Johnson & Johnson (JNJ) maintained its EPS guidance from a prior range of $11.43 - $11.63 to $11.45 - $11.65 for the fiscal year 2026.
When did Johnson & Johnson (JNJ) last issue guidance?
Johnson & Johnson (JNJ) last issued guidance on April 14, 2026 for the fiscal year 2026.
